Literature DB >> 23020091

Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.

Dongjiao Fan1, Xiaorong Wu, Wenna Dong, Wei Sun, Jinzhuo Li, Xing Tang.   

Abstract

The aim of the investigation was to compare the effectiveness of two absorption enhancers, sodium caprate (C10) and sodium deoxycholate (SDC), in increasing the bioavailability of a poorly absorbed paracellar flux drug, berberine chloride, across the intestinal mucosae of rats in vivo, together with examination of their effects on mucosal damage. In addition, all four intestinal segments were collected after administration of the enhancers and sodium saline. The results of the bioavailability experiments showed the oral absorption of berberine chloride was poor and both C10 and SDC could significantly improve the very poor absorption of berberine chloride. After co-administration, the area under the plasma concentration-time curve of berberine chloride was increased 41.1-fold by C10 (100 mg/kg) and 35.3-fold by SDC (100 mg/kg) compared with that in the absence of C10 and SDC, respectively. Local toxicity experiment indicated that both enhancers caused no specific damage to the intact intestine. This study demonstrates that C10 and SDC could significantly promote the absorption of berberine chloride from the gastrointestinal tract with few toxic effects, which might be due mainly to relaxing the absorption limitation while inhibiting the efflux transporter of berberine chloride by the enhancers. Besides, this could lead to the development of new drug-enhancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020091     DOI: 10.3109/03639045.2012.723219

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

Review 1.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

2.  Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.

Authors:  David J Brayden; Edwin Walsh
Journal:  AAPS J       Date:  2014-06-25       Impact factor: 4.009

3.  Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota.

Authors:  Feifei Qiu; Weihui Lu; Shulin Ye; Huazhen Liu; Qiaohuang Zeng; Haiding Huang; Chun-Ling Liang; Yuchao Chen; Fang Zheng; Qunfang Zhang; Chuan-Jian Lu; Zhenhua Dai
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

4.  Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.

Authors:  Chandraiah Godugu; Apurva R Patel; Ravi Doddapaneni; Jaganmohan Somagoni; Mandip Singh
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 5.  Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis.

Authors:  Yanwen Wang; Jeffrey A Zidichouski
Journal:  Cholesterol       Date:  2018-07-02

6.  Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases.

Authors:  Hui-Hui Guo; Chen-Lin Feng; Wen-Xuan Zhang; Zhi-Gang Luo; Hong-Juan Zhang; Ting-Ting Zhang; Chen Ma; Yun Zhan; Rui Li; Song Wu; Zeper Abliz; Cong Li; Xiao-Lin Li; Xiao-Lei Ma; Lu-Lu Wang; Wen-Sheng Zheng; Yan-Xing Han; Jian-Dong Jiang
Journal:  Nat Commun       Date:  2019-04-30       Impact factor: 14.919

Review 7.  Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.

Authors:  Maisarah Azman; Akmal H Sabri; Qonita Kurnia Anjani; Mohd Faiz Mustaffa; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08

Review 8.  Trends in drug delivery through tissue barriers containing tight junctions.

Authors:  Christian Tscheik; Ingolf E Blasig; Lars Winkler
Journal:  Tissue Barriers       Date:  2013-04-01

Review 9.  Nutraceuticals in hypercholesterolaemia: an overview.

Authors:  Antonello Santini; Ettore Novellino
Journal:  Br J Pharmacol       Date:  2016-10-29       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.